OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer

NCT05935774 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Withdrawn prior to opening to accrual.

Conditions

Metastatic Lung Non-Small Cell Carcinoma
Recurrent Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8

Interventions

BIOLOGICAL: Atezolizumab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Electronic Health Record Review
PROCEDURE: Magnetic Resonance Imaging
DRUG: Trabedersen (OT-101)

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]